BFC Planning’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
BFC Planning's LTGO Position: Q3 2026 in Review
BFC Planning opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 273 shares worth $4.56K. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings.
28 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- BFC Planning held 273 shares of Latigo Biotherapeutics worth $4.56K as of Q3 2026.
- Latigo Biotherapeutics was a new BFC Planning position in Q3 2026.
- Latigo Biotherapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2722 holding.
- 28 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.